Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Medulloblastoma × fenofibric acid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Recurrence 1 Medulloblastoma 1 Ependymoma 1

Interventions

Cyclophosphamide 32 Temozolomide 30 Filgrastim 24 Carboplatin 23 Etoposide 22 Vincristine 18 Radiotherapy 18 Cisplatin 18 Magnetic Resonance Spectroscopy 15 Thiotepa 13 Irinotecan 12 Granulocyte Colony-Stimulating Factor 11 Peripheral Blood Stem Cell Transplantation 10 Melphalan 9 Lomustine 9 Topotecan 8 Specimen Handling 8 Methotrexate 8 etoposide phosphate 7 Radiation 7 X-Rays 6 Phantoms, Imaging 6 Biopsy 6 sonidegib 5 sargramostim 5 Platinum 5 Nuclear Medicine Department, Hospital 5 Busulfan 5 Bevacizumab 5 1,2-diaminocyclohexaneplatinum II citrate 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01356290 2026-02-23

MEMMAT

Medical University of Vienna

Phase 2 Recruiting

Ependymoma, Medulloblastoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡